Deals - Diagnostic Devices

Boston Scientific to buy prostate therapy developer Augmenix in $600m deal

Medical technology firm Boston Scientific has agreed to acquire US-based prostate therapy developer Augmenix in an agreement valued at around $600m.

UL buys UK human factors company Medical Device Usability

UL has acquired Medical Device Usability, a UK-based human factors services business that specializes in medical technology, particularly medical devices, drug delivery products, and in-vitro diagnostic devices.

Bruker to buy majority stake in molecular diagnostics solutions provider Hain Lifescience

Bruker has agreed to purchase a majority stake in Germany-based infectious disease-focused molecular diagnostics (MDx) firm Hain Lifescience for an undisclosed sum.

Pentax Medical buys majority interest in PlasmaBiotics

Pentax Medical, a division of Hoya Group, has purchased a controlling stake in French firm PlasmaBiotics for an undisclosed sum.

Hologic buys digital radiography solutions provider Faxitron Bioptics

Medical technology firm Hologic has acquired digital radiography solutions provider Faxitron Bioptics for about $85m.

Elekta acquires quality assurance firm Acumyn

Elekta has acquired Canadian quality assurance (QA) company Acumyn, a stand-alone commercial spin-off of University Hospital Network, Toronto.

Kypha buys diagnostics platform and contract development firm Biosensia

Medical diagnostics firm Kypha has acquired diagnostics platform and contract development firm, Biosensia for an undisclosed sum.

Cue Health awarded $30m base funding from US Department of Health and Human Services’ BARDA

Healthcare technology Cue Health (Cue) has secured $30m in base funding and option from the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA).

NOW Diagnostics buys rapid assay reader technology from CELLMIC

NOW Diagnostics has acquired CELLMIC’s rapid assay reader product lines and related assets for an undisclosed price in a move to strengthen its rapid diagnostics and point-of-care testing capabilities.